Претраживање
Приказ резултата 1-2 од 2
Suppressing prostate cancer by targeting NGAL
(International Journal of Molecular Medicine, 2014)
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer
(International Journal of Molecular Medicine, 2014)